A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study

被引：0
|
作者：
Y Nakai
H Isayama
T Sasaki
N Sasahira
T Tsujino
N Toda
H Kogure
S Matsubara
Y Ito
O Togawa
T Arizumi
K Hirano
M Tada
M Omata
K Koike
机构：
[1] Graduate School of Medicine,Department of Gastroenterology
[2] The University of Tokyo,Department of Gastroenterology
[3] Mitsui Memorial Hospital,Department of Gastroenterology
[4] Kanto Central Hospital,Department of Gastroenterology
[5] Japanese Red Cross Hospital,Department of Gastroenterology
[6] JR Tokyo General Hospital,Department of Gastroenterology
[7] Teikyo Chiba Medical Center,undefined
[8] Yamanashi Prefectural Hospital Organization,undefined
来源：
British Journal of Cancer | 2012年 / 106卷
关键词：
chemotherapy; gemcitabine; pancreatic cancer; randomised controlled trial; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1934 / 1939
页数：5
相关论文
共 50 条
  • [41] Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer
    Ioka, T.
    Komatsu, Y.
    Mizuno, N.
    Tsuji, A.
    Ohkawa, S.
    Tanaka, M.
    Iguchi, H.
    Ishiguro, A.
    Kitano, M.
    Satoh, T.
    Yamaguchi, T.
    Takeda, K.
    Kida, M.
    Eguchi, K.
    Ito, T.
    Munakata, M.
    Itoi, T.
    Furuse, J.
    Hamada, C.
    Sakata, Y.
    BRITISH JOURNAL OF CANCER, 2017, 116 (04) : 464 - 471
  • [42] Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)
    Masato Ozaka
    Yuji Matsumura
    Hiroshi Ishii
    Yasushi Omuro
    Takao Itoi
    Hisatsugu Mouri
    Keiji Hanada
    Yasutoshi Kimura
    Iruru Maetani
    Yoshinobu Okabe
    Masaji Tani
    Takaaki Ikeda
    Susumu Hijioka
    Ryouhei Watanabe
    Shinya Ohoka
    Yuki Hirose
    Masafumi Suyama
    Naoto Egawa
    Atsushi Sofuni
    Takaaki Ikari
    Toshifusa Nakajima
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1197 - 1204
  • [43] Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer
    T Ioka
    Y Komatsu
    N Mizuno
    A Tsuji
    S Ohkawa
    M Tanaka
    H Iguchi
    A Ishiguro
    M Kitano
    T Satoh
    T Yamaguchi
    K Takeda
    M Kida
    K Eguchi
    T Ito
    M Munakata
    T Itoi
    J Furuse
    C Hamada
    Y Sakata
    British Journal of Cancer, 2017, 116 : 464 - 471
  • [44] Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer A Systematic Review and Meta-Analysis
    Li, Doudou
    Chen, Changhao
    Zhou, Yu
    Chen, Rufu
    Fan, Xinxiang
    Bi, Zhuofei
    Li, Zhihua
    Liu, Yimin
    MEDICINE, 2015, 94 (35) : e1345
  • [45] Phase II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients
    Morizane, C.
    Okusaka, T.
    Ikeda, M.
    Furuse, J.
    Ohkawa, S.
    Nakachi, K.
    Suzuki, E.
    Ueno, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 388 - 388
  • [46] Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
    Reni, M
    Cordio, S
    Milandri, C
    Passoni, P
    Bonetto, E
    Oliani, C
    Luppi, G
    Nicoletti, R
    Galli, L
    Bordonaro, R
    Passardi, A
    Zerbi, A
    Balzano, G
    Aldrighetti, L
    Staudacher, C
    Villa, E
    Di Carlo, V
    LANCET ONCOLOGY, 2005, 6 (06): : 369 - 376
  • [47] A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Sasahira, Naoki
    Ito, Yukiko
    Kogure, Hirofumi
    Togawa, Osamu
    Matsubara, Saburo
    Arizumi, Toshihiko
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Mizuno, Suguru
    Yamamoto, Keisuke
    Hirano, Kenji
    Tsujino, Takeshi
    Ijichi, Hideaki
    Toda, Nobuo
    Tada, Minoru
    Kawabe, Takao
    Omata, Masao
    ONCOLOGY, 2009, 77 (05) : 300 - 303
  • [48] Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer
    K Nakamura
    T Yamaguchi
    T Ishihara
    K Sudo
    H Kato
    H Saisho
    British Journal of Cancer, 2006, 94 : 1575 - 1579
  • [49] Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer
    Nakamura, K.
    Yamaguchi, T.
    Ishihara, T.
    Sudo, K.
    Kato, H.
    Saisho, H.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1575 - 1579
  • [50] Combination therapy of gemcitabine and S-1 in patients with metastatic pancreatic cancer
    Yamaguchi, Taketo
    Nakamura, Kazuyoshi
    Sudou, Kentarou
    Hara, Tarou
    Denda, Tadamichi
    Ishihara, Takeshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A89 - A89
12345